Association between metabolic syndrome and chronic kidney disease in perimenopausal women

International Journal of Environmental Research and Public Health

Volumn 10, Issue 9, 2013, Pages 3987-3997

  Li, Yongqiang ^a   Zhao, Liqin ^a   Chen, Youming ^a   Liu, Aiqun ^a   Liu, Xinyu ^a   Shao, Xiaofei ^a   Zhang, Ying ^a   Wang, Honglei ^a   Wang, Xiaohong ^a   Li, Bin ^a   Deng, Kangping ^a   Liu, Qin ^a   Holthöfer, Harry ^b   Zou, Hequn ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Chronic kidney disease; Metabolic syndrome; Perimenopausal women

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ENDOCRINE SYSTEM DISORDER; MEDICINE; METABOLISM; OBESITY; WOMENS HEALTH;

ABDOMINAL OBESITY; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; SOCIOECONOMICS;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHINA; CHOLESTEROL, HDL; FEMALE; HUMANS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PERIMENOPAUSE; RENAL INSUFFICIENCY, CHRONIC; TRIGLYCERIDES;

EID: 84883731328     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph10093987     Document Type: Article

References (29)

1. Nikolic, D.; Nikfar, S.; Salari, P.; Rizzo, M.; Ray, K.K.; Pencina, M.J.; Mikhailidis, D.P.; Toth, P.P.; Nicholls, S.J.; Rysz, J.; et al. Effects of statins on lipid profile in chronic kidney disease patients: A meta-analysis of randomized controlled trials. Curr. Med. Res. Opin. 2013, 29, 435-451.
2. Barylski, M.; Nikfar, S.; Mikhailidis, D.P.; Toth, P.P.; Salari, P.; Ray, K.K.; Pencina, M.J.; Rizzo, M.; Rysz, J.; Abdollahi, M.; et al. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacol. Res. 2013, 72, 35-44.
3. Athyros, V.G.; Hatzitolios, A.I.; Karagiannis, A.; Savopoulos, C.; Katsiki, N.; Tziomalos, K.; Papagianni, A.; Kakafika, A.; Gossios, T.D.; Mikhailidis, D.P.; et al. Improving the implementation of current guidelines for the management of major coronary heart disease risk factors by multifactorial intervention. The imperative renal analysis. Arch. Med. Sci. 2011, 7, 984-992.
4. Barylski, M.; Małyszko, J.; Rysz, J.; Myśliwiec, M.; Banach, M. Lipids, blood pressure, kidney-What was new in 2011? Arch. Med. Sci. 2011, 7, 1055-1066.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1-S266.
6. Zhang, L.; Wang, F.; Wang, L.; Wang, W.; Liu, B.; Liu, J.; Chen, M.; He, Q.; Liao, Y.; Yu, X.; et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012, 379, 815-822.
7. Coresh, J.; Selvin, E.; Stevens, L.A.; Manzi, J.; Kusek, J.W.; Eggers, P.; van Lente, F.; Levey, A.S. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298, 2038-2047.
8. Meguid, E.L.; Nahas, A.; Bello, A.K. Chronic kidney disease: The global challenge. Lancet 2005, 365, 331-340.
9. Muntner, P.; He, J.; Hamm, L.; Loria, C.; Whelton, P.K. Renal insuficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Nephrol. 2002, 13, 745-753.
10. Malyszko, J.; Banach, M. Prediabetes, Prehypertension-Do We Need Pre-CKD? Curr. Vasc. Pharmacol. 25 April 2013. Available online: http://www.ncbi.nlm.nih.gov/pubmed/23627978 (accessed on 26 August 2013).
11. Curhan, G.C. Prediabetes, prehypertension-Is it time for pre-CKD? Clin. J. Am. Soc. Nephrol. 2010, 5, 557-559.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285, 2486-2497.
13. Tozawa, M.; Iseki, C.; Tokashiki, K.; Chinen, S.; Kohagura, K.; Kinjo, K.; Takishita, S.; Iseki, K. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res. 2007, 30, 937-943.
14. Prior, J.C. Perimenopause: The complex endocrinology of the menopausal transition. Endocr. Rev. 1998, 19, 397-428.
15. Jesmin, S.; Islam, A.S.; Akter, S.; Islam, M.M.; Sultana, S.N.; Yamaguchi, N.; Okazaki, O.; Moroi, M.; Hiroe, M.; Kimura, S.; et al. Metabolic syndrome among pre-and post-menopausal rural women in Bangladesh: Result from a population-based study. BMC Res. Notes 2013, 6, 157. doi: 10.1186/1756-0500-6-157.
16. Salve, H.; Mahajan, S.; Misra, P. Prevalence of chronic kidney diseases and its determinants among perimenopausal women in a rural area of North India: A community-based study. Indian J. Nephrol. 2012, 22, 438-443.
17. Ostlund, R.E., Jr.; Staten, M.; Kohrt, W.M.; Schultz, J.; Malley, M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N. Engl. J. Med. 1990, 322, 229-234.
18. Knapp, M.L.; Hadid, O. Investigations into the negative interference by jaundiced plasma in kinetic Jaffe's methods for plasma creatinine estimation. Ann. Clin. Biochem. 1987, 24, 85-97.
19. Gundogan, K.; Bayram, F.; Gedik, V.; Kaya, A.; Karaman, A.; Demir, O.; Sabuncu, T.; Kocer, D.; Coskun, R. Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch. Med. Sci. 2013, 9, 243-253.
20. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr.; et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640-1645.
21. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome Part 1: Worldwide Definition for Use in Clinical Practice. Available online: http://www.idf.org/webdata/docs/IDF_metasyndrome_definition.pdf (accessed on 11 May 2007).
22. Levey, A.S.; Coresh, J.; Balk, E.; Kausz, A.T.; Levin, A.; Steffes, M.W.; Hogg, R.J.; Perrone, R.D.; Lau, J.; Eknoyan, G.; et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann. Intern. Med. 2003, 139, 137-147.
23. Lakka, H.M.; Laaksonen, D.E.; Lakka, T.A.; Niskanen, L.K.; Kumpusalo, E.; Tuomilehto, J.; Salonen, J.T. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002, 288, 2709-2716.
24. Laaksonen, D.E.; Lakka, H.M.; Niskanen, L.K.; Kaplan, G.A.; Salonen, J.T.; Lakka, T.A. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 2002, 156, 1070-1077.
25. Gharipour, M.; Kelishadi, R.; Khosravi, A.; Shirani, S.; Masjedi, M.; Sarrafzadegan, N. The impact of a community trial on the pharmacological treatment in the individuals with the metabolic syndrome: Findings from the Isfahan Healthy Heart Program, 2001-2007. Arch. Med. Sci. 2012, 8, 1009-1017.
26. Chen, J.; Muntner, P.; Hamm, L.L.; Jones, D.W.; Batuman, V.; Fonseca, V.; Whelton, P.K.; He, J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med. 2004, 140, 167-174.
27. Gluba, A.; Mikhailidis, D.P.; Lip, G.Y.; Hannam, S.; Rysz, J.; Banach, M. Metabolic syndrome and renal disease. Int. J. Cardiol. 2013, 164, 141-150.
28. Kurella, M.; Lo, J.C.; Chertow, G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J. Am. Soc. Nephrol. 2005, 16, 2134-2140.
29. Zhang, L.; Zuo, L.; Wang, F.; Wang, M.; Wang, S.; Liu, L.; Wang, H. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin. Proc. 2007, 82, 822-827.